Quality of Life Study About the Role of Turbinectomy in Rhinoseptoplasty (WHOQOL-BREF)

January 16, 2019 updated by: Hospital de Clinicas de Porto Alegre

The Role of Turbinectomy in Rhinoseptoplasty: a Randomized Clinical Trial With Evaluation of Quality of Life

Research Question: Performing partial turbinectomy associated with rhinoseptoplasty is responsible for an increase in quality of life related to nasal obstruction when compared to no intervention in rhinoseptoplasty inferior turbinate?

  • Population: patients eligible for functional rhinoseptoplasty and / or aesthetic
  • Intervention: surgery, turbinectomy of inferior turbinates
  • Comparison: the absence of intervention in inferior turbinates
  • Primary endpoint: Quality of life related to nasal obstruction

Study Overview

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Rio Grande Do Sul
      • Porto Alegre, Rio Grande Do Sul, Brazil, 90035-903
        • Hospital de Clinicas de Porto Alegre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 months to 90 years (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Eligible patients to rhinoseptoplasty
  • Patients who agreed to participate

Exclusion Criteria:

  • Presence of symptoms of nasal obstruction in the absence of septal deviation, poor support of the nasal tip or clamping of the nasal valve;
  • Presence of hypertrophic and obstructive inferior turbinates;
  • Presence of sinonasal tumors;
  • Patients undergoing treatment of other concomitant rhinoplasty entities such as inflammatory sinus pathology, adenoid hypertrophy, septal perforation, otoplasty and blepharoplasty.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Rhinoseptoplasty and turbinectomy
Patients submitted to rhinoseptoplasty associated to Endoscopic partial turbinectomy.
Rhinoseptoplasty without turbinectomy procedure
After medial dislocation of the inferior turbinate, proceed partial resection of the inferior turbinate in all its inferior extension in range. Possible bleeding is cauterized.
Other Names:
  • Turbinectomy
Endoscopy to medial dislocation of the inferior turbinate with instrument
ACTIVE_COMPARATOR: Rhinoseptoplasty
Patients submitted only to rhinoseptoplasty, without turbinectomy procedure.
Rhinoseptoplasty without turbinectomy procedure

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life related to nasal obstruction
Time Frame: 3 months
Quality of life will be evaluated by the WHOQOL-BREF instrument, that comprises 26 items, which measure the following broad domains: physical health, psychological health, social relationships, and environment.
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oral antihistamine
Time Frame: 3 months
At 90 posoperative day patients were asked if they had used oral antihistamine in the past 30 days or not
3 months
Nasal sneezing
Time Frame: 3 MONTHS
At 90 posoperative day patients were asked if they had nasal sneezing for more than one hour a day on most days, or not.
3 MONTHS
Nasal Rhinorrhea
Time Frame: 3 MONTHS
At 90 posoperative day patients were asked if they had nasal rhinorrhea for more than one hour a day on most days, or not.
3 MONTHS
Nasal Pruritis
Time Frame: 3 MONTHS
At 90 posoperative day patients were asked if they had nasal pruritis for more than one hour a day on most days, or not.
3 MONTHS
Allergic Conjunctivitis
Time Frame: 3 months
At 90 posoperative day patients were asked if they had allergic conjunctivitis for more than one hour a day on most days, or not.
3 months
Topical Nasal Corticosteroids
Time Frame: 3 MONTHS
At 90 posoperative day patients were asked if they were using topic nasal corticosteroids or not
3 MONTHS

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Bianca H Moura, MD, Hospital de Clinicas de Porto Alegre
  • Principal Investigator: Michelle Lavinsky, PhD, Hospital de Clinicas de Porto Alegre

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2014

Primary Completion (ACTUAL)

March 1, 2015

Study Completion (ACTUAL)

July 1, 2016

Study Registration Dates

First Submitted

September 2, 2014

First Submitted That Met QC Criteria

September 3, 2014

First Posted (ESTIMATE)

September 4, 2014

Study Record Updates

Last Update Posted (ACTUAL)

January 17, 2019

Last Update Submitted That Met QC Criteria

January 16, 2019

Last Verified

January 1, 2019

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 130516

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Deviated Nasal Septum

Subscribe